financetom
Business
financetom
/
Business
/
Lam Research Unusual Options Activity For March 28
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Lam Research Unusual Options Activity For March 28
Mar 28, 2024 8:33 AM

Deep-pocketed investors have adopted a bullish approach towards Lam Research ( LRCX ) , and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in LRCX usually suggests something big is about to happen.

We gleaned this information from our observations today when Benzinga's options scanner highlighted 10 extraordinary options activities for Lam Research ( LRCX ). This level of activity is out of the ordinary.

The general mood among these heavyweight investors is divided, with 50% leaning bullish and 50% bearish. Among these notable options, 2 are puts, totaling $58,160, and 8 are calls, amounting to $399,018.

Projected Price Targets

Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $920.0 to $1045.0 for Lam Research ( LRCX ) over the recent three months.

Volume & Open Interest Trends

In terms of liquidity and interest, the mean open interest for Lam Research ( LRCX ) options trades today is 124.38 with a total volume of 127.00.

In the following chart, we are able to follow the development of volume and open interest of call and put options for Lam Research's ( LRCX ) big money trades within a strike price range of $920.0 to $1045.0 over the last 30 days.

Lam Research 30-Day Option Volume & Interest Snapshot

Biggest Options Spotted:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Strike Price Total Trade Price Open Interest Volume
LRCX CALL SWEEP BULLISH 04/05/24 $980.00 $130.4K 150 93
LRCX CALL SWEEP BULLISH 04/05/24 $920.00 $65.0K 3 0
LRCX CALL TRADE BULLISH 03/28/24 $950.00 $47.0K 105 0
LRCX CALL SWEEP BEARISH 04/19/24 $970.00 $43.9K 74 0
LRCX CALL SWEEP BULLISH 04/26/24 $1045.00 $33.8K 0 0

About Lam Research

Lam Research ( LRCX ) is one of the largest semiconductor wafer fabrication equipment, or WFE, manufacturers in the world. It specializes in the market segments of deposition and etch, which entail the buildup of layers on a semiconductor and the subsequent selective removal of patterns from each layer. Lam holds the top market share in etch and holds the clear cut second share in deposition. It is more exposed to memory chipmakers for DRAM and NAND chips. It counts as top customers the largest chipmakers in the world, including TSMC, Samsung, Intel, and Micron.

Present Market Standing of Lam Research

Trading volume stands at 68,232, with LRCX's price up by 0.11%, positioned at $966.74.

RSI indicators show the stock to be may be approaching overbought.

Earnings announcement expected in 20 days.

Expert Opinions on Lam Research

Over the past month, 3 industry analysts have shared their insights on this stock, proposing an average target price of $976.6666666666666.

In a cautious move, an analyst from Cantor Fitzgerald downgraded its rating to Neutral, setting a price target of $900.

An analyst from Cantor Fitzgerald has revised its rating downward to Neutral, adjusting the price target to $900.

Maintaining their stance, an analyst from UBS continues to hold a Buy rating for Lam Research ( LRCX ), targeting a price of $1130.

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Lam Research ( LRCX ) options trades with real-time alerts from Benzinga Pro.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Liberty Media's MotoGP Deal Faces Delay as EU Extends Review
Liberty Media's MotoGP Deal Faces Delay as EU Extends Review
Jan 22, 2025
12:43 PM EST, 01/22/2025 (MT Newswires) -- Liberty Media's ( LLYVB ) planned acquisition of MotoGP faces a potential delay as the European Commission extended its review of the deal by 20 working days, according to a filing posted on the regulator's website. June 16 is the new deadline for the EU merger watchdog to decide on the deal, according...
Rail Vision Shares Surge After Sujan Ventures Agrees To Advance Safety Systems
Rail Vision Shares Surge After Sujan Ventures Agrees To Advance Safety Systems
Jan 22, 2025
Rail Vision Ltd. ( RVSN ) shares are trading higher after the company inked a binding memorandum of understanding with Sujan Ventures in India to introduce its safety systems to the Indian railway market. Sujan Ventures will make an initial upfront payment to the company, with additional payments tied to milestone completion. As per the deal, Sujan Ventures will spearhead...
Performance Shipping Extends Charter for Aframax Tanker With ST Shipping
Performance Shipping Extends Charter for Aframax Tanker With ST Shipping
Jan 22, 2025
12:31 PM EST, 01/22/2025 (MT Newswires) -- Performance Shipping ( PSHG ) said Wednesday it extended its time charter contract for Aframax tanker P. Monterey with ST Shipping & Transport at a gross rate of $28,000 per day for a period around 12 months. The charter commenced in mid-January and will generate $9.4 million in gross revenue for the minimum...
BioAffinity Technologies Says Australian Patent Office Accepts Lung Cancer Test Application
BioAffinity Technologies Says Australian Patent Office Accepts Lung Cancer Test Application
Jan 22, 2025
12:32 PM EST, 01/22/2025 (MT Newswires) -- BioAffinity Technologies ( BIAF ) said the Australian patent office accepted its patent application for the method used in the CyPath Lung diagnostic test for predicting lung cancer. The Australian patent, expected to be issued in three months, will expire in 2042 and will be the second patent for the CyPath Lung test,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved